NEIL GARRY ARTHUR 4
4 · Avalo Therapeutics, Inc. · Filed Apr 1, 2025
Insider Transaction Report
Form 4
NEIL GARRY ARTHUR
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2025-03-28+64,867→ 64,927 total - Exercise/Conversion
Restricted Stock Units
2025-03-28+64,867→ 129,733 total→ Common Stock (64,867 underlying) - Tax Payment
Common Stock
2025-03-28$8.46/sh−17,787$150,478→ 47,140 total
Footnotes (2)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On August 13, 2024, the Reporting Person was granted 194,600 restricted stock units, vesting 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person's continued service on such vesting date.